17-45255781-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152343.3(SPATA32):c.401G>A(p.Arg134Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000359 in 1,613,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152343.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152114Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251410Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135874
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1461758Hom.: 0 Cov.: 34 AF XY: 0.0000413 AC XY: 30AN XY: 727170
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152114Hom.: 0 Cov.: 31 AF XY: 0.000108 AC XY: 8AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.401G>A (p.R134Q) alteration is located in exon 4 (coding exon 4) of the SPATA32 gene. This alteration results from a G to A substitution at nucleotide position 401, causing the arginine (R) at amino acid position 134 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at